Gabapentin

K K Jain MD (Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Originally released December 16, 1998; last updated September 19, 2016; expires September 19, 2019

Historical note and terminology

The era of antiepileptic drugs started with the introduction of bromides in 1857, and was followed by the discovery of the anticonvulsant effect of barbiturates in 1912 and by the introduction of hydantoins in 1916. Carbamazepine was introduced into clinical practice as an antiepileptic drug in 1963. Carbamazepine and lamotrigine block repetitive firing of neurons by blocking sodium channels. Gabapentin, a GABA receptor agonist, was first studied as an antiepileptic drug in humans in 1987 (Crawford et al 1987). It was launched in the United Kingdom in 1993 and approved in the United States as add-on therapy for intractable partial seizures in adults. It is also approved for the treatment of postherpetic neuralgia.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.